Lipocine LPCN
NASDAQ LPCN
$1.59 -0.03 (-1.85%)
As of: Oct 21, 2026 · 3:12 PM EDT

Lipocine (LPCN) Preferred Shares (2023)

Updated

Lipocine (LPCN) posted Preferred Shares of $9.00 for Q1 2023.

Analysis

Lipocine (LPCN) Preferred Shares (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,137.48 Bn 1,106.07 Bn 19.71 Bn -
2 Johnson & Johnson 618.81 Bn 537.34 Bn 17.26 Bn -
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn -
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn -
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn -
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn -
7 Amgen 236.67 Bn 192.07 Bn 7.24 Bn -
8 Gilead Sciences 191.16 Bn 165.36 Bn 6.22 Bn -
9 Pfizer 169.69 Bn 116.34 Bn 10.94 Bn -
10 Lipocine 8.61 Mn -59.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 9.00
API Access

Lipocine Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=LPCN&period=max&api_key=YOUR_API_KEY